Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson's disease.

Peoples C, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J.

Parkinsonism Relat Disord. 2012 Jun;18(5):469-76. doi: 10.1016/j.parkreldis.2012.01.005. Epub 2012 Jan 28.

PMID:
22285756
2.

Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment.

Shaw VE, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J.

J Comp Neurol. 2010 Jan 1;518(1):25-40. doi: 10.1002/cne.22207.

PMID:
19882716
3.

Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains.

Moro C, Torres N, El Massri N, Ratel D, Johnstone DM, Stone J, Mitrofanis J, Benabid AL.

BMC Neurosci. 2013 Mar 27;14:40. doi: 10.1186/1471-2202-14-40.

4.

The effect of different doses of near infrared light on dopaminergic cell survival and gliosis in MPTP-treated mice.

El Massri N, Johnstone DM, Peoples CL, Moro C, Reinhart F, Torres N, Stone J, Benabid AL, Mitrofanis J.

Int J Neurosci. 2016;126(1):76-87. doi: 10.3109/00207454.2014.994063. Epub 2015 Jan 7.

PMID:
25469453
5.

Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus.

Shaw VE, Keay KA, Ashkan K, Benabid AL, Mitrofanis J.

Parkinsonism Relat Disord. 2010 Jun;16(5):338-44. doi: 10.1016/j.parkreldis.2010.02.008. Epub 2010 Mar 12.

PMID:
20227323
6.

Saffron pre-treatment offers neuroprotection to Nigral and retinal dopaminergic cells of MPTP-Treated mice.

Purushothuman S, Nandasena C, Peoples CL, El Massri N, Johnstone DM, Mitrofanis J, Stone J.

J Parkinsons Dis. 2013;3(1):77-83. doi: 10.3233/JPD-130173.

PMID:
23938314
7.

Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease.

Schintu N, Frau L, Ibba M, Garau A, Carboni E, Carta AR.

Neurotox Res. 2009 Aug;16(2):127-39. doi: 10.1007/s12640-009-9061-x. Epub 2009 May 27.

PMID:
19526289
8.

Photobiomodulation inside the brain: a novel method of applying near-infrared light intracranially and its impact on dopaminergic cell survival in MPTP-treated mice.

Moro C, Massri NE, Torres N, Ratel D, De Jaeger X, Chabrol C, Perraut F, Bourgerette A, Berger M, Purushothuman S, Johnstone D, Stone J, Mitrofanis J, Benabid AL.

J Neurosurg. 2014 Mar;120(3):670-83. doi: 10.3171/2013.9.JNS13423. Epub 2013 Oct 25.

PMID:
24160475
9.

The impact of near-infrared light on dopaminergic cell survival in a transgenic mouse model of parkinsonism.

Purushothuman S, Nandasena C, Johnstone DM, Stone J, Mitrofanis J.

Brain Res. 2013 Oct 16;1535:61-70. doi: 10.1016/j.brainres.2013.08.047. Epub 2013 Aug 30.

PMID:
23998985
10.

Does melatonin help save dopaminergic cells in MPTP-treated mice?

Ma J, Shaw VE, Mitrofanis J.

Parkinsonism Relat Disord. 2009 May;15(4):307-14. doi: 10.1016/j.parkreldis.2008.07.008. Epub 2008 Sep 14.

PMID:
18793863
11.

Survival of Dopaminergic Amacrine Cells after Near-Infrared Light Treatment in MPTP-Treated Mice.

Peoples C, Shaw VE, Stone J, Jeffery G, Baker GE, Mitrofanis J.

ISRN Neurol. 2012;2012:850150. doi: 10.5402/2012/850150. Epub 2012 May 30.

12.

Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.

Neurobiol Dis. 2012 Mar;45(3):1051-67. doi: 10.1016/j.nbd.2011.12.024. Epub 2011 Dec 14.

PMID:
22198503
13.

The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.

Ding YX, Xia Y, Jiao XY, Duan L, Yu J, Wang X, Chen LW.

Neurochem Res. 2011 Oct;36(10):1759-66. doi: 10.1007/s11064-011-0491-5. Epub 2011 May 12.

PMID:
21562748
14.

810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated mice.

Reinhart F, Massri NE, Darlot F, Torres N, Johnstone DM, Chabrol C, Costecalde T, Stone J, Mitrofanis J, Benabid AL, Moro C.

Neurosci Res. 2015 Mar;92:86-90. doi: 10.1016/j.neures.2014.11.005. Epub 2014 Nov 25.

PMID:
25462595
15.

Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.

Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC.

J Neurochem. 2002 Aug;82(3):615-24.

16.

Intracranial application of near-infrared light in a hemi-parkinsonian rat model: the impact on behavior and cell survival.

Reinhart F, Massri NE, Chabrol C, Cretallaz C, Johnstone DM, Torres N, Darlot F, Costecalde T, Stone J, Mitrofanis J, Benabid AL, Moro C.

J Neurosurg. 2016 Jun;124(6):1829-41. doi: 10.3171/2015.5.JNS15735. Epub 2015 Nov 27.

PMID:
26613166
17.

Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism.

Tatton WG, Greenwood CE.

J Neurosci Res. 1991 Dec;30(4):666-72.

PMID:
1686284
19.

Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism - an abscopal neuroprotective effect.

Johnstone DM, el Massri N, Moro C, Spana S, Wang XS, Torres N, Chabrol C, De Jaeger X, Reinhart F, Purushothuman S, Benabid AL, Stone J, Mitrofanis J.

Neuroscience. 2014 Aug 22;274:93-101. doi: 10.1016/j.neuroscience.2014.05.023. Epub 2014 May 21.

PMID:
24857852
20.

Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.

Shin JY, Park HJ, Ahn YH, Lee PH.

J Neurochem. 2009 Nov;111(4):1042-50. doi: 10.1111/j.1471-4159.2009.06381.x. Epub 2009 Sep 16.

Supplemental Content

Support Center